Nivolumab-induced myocarditis complicated by complete atrioventricular block in a patient with metastatic non-small cell lung cancer
Date
2019
Authors
Tan, J.L.
Mugwagwa, A.N.
Cieslik, L.
Joshi, R.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
BMJ Case Reports, 2019; 12(7):229963-1-229963-5
Statement of Responsibility
Jin Lin Tan, Augustine Nyasha Mugwagwa, Luke Cieslik, Rohit Joshi
Conference Name
Abstract
We report a case of a 74-year-old man who developed myocarditis complicated by atrioventricular (AV) block following two doses of nivolumab for the treatment of non-small cell lung cancer. A diagnosis of drug-induced acute myocarditis with complete AV block was considered on the basis of elevated troponin, new onset left ventricular (LV) systolic dysfunction, absence of acute myocardial infarction and some findings suggestive of myocarditis on cardiac magnetic resonance. The patient was commenced on glucocorticoids, perindopril and carvedilol. AV block and LV dysfunction persisted despite 2 weeks of treatment. He ultimately became hypotensive which prompted an implantation of a cardiac resynchronisation therapy pacemaker. Follow-up echocardiogram at 6 weeks showed resolution of LV systolic dysfunction. However, he continued to have AV block.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.